In an analysis of the past several years of Hepatitis C drug evolution, the costly factors of development, competition, and marketing are examined. Second and third generation Hep C drugs have finally taken hold, recouping multi-billion dollar development costs. With treatment prices in the tens and hundreds of thousands, increased competition in the market raises hopes of lower prices for more effective drugs. Read more science20.com/pfired_but_st...
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.